Adjuvant Paclitaxel/Gemcitabine/Cisplatin Improves Survival in Patients With Resected Locally Invasive Bladder Cancer

Capsule Summary - Compared with observation, adjuvant PGC significantly improved all efficacy outcomes, including OS, in patients with resected invasive transitional cell carcinoma of the bladder.
Source: Clinical Care Options Oncology - Prostate Cancer - Category: Cancer & Oncology Source Type: research